Role of action potentials and calcium influx in ATP- and UDP-induced noradrenaline release from rat cultured sympathetic neurones

被引:33
作者
von Kügelgen, I
Nörenberg, W
Meyer, A
Illes, P
Starke, K
机构
[1] Univ Freiburg, Inst Pharmakol, D-79104 Freiburg, Germany
[2] Univ Leipzig, Inst Pharmakol, D-04107 Leipzig, Germany
关键词
rat sympathetic neurones; P2X-receptor; uracil nucleotide receptor; alpha(2)-adrenoceptor; action potential; calcium influx; noradrenaline release;
D O I
10.1007/PL00005362
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Adenine and uracil nucleotides release noradrenaline from rat postganglionic sympathetic neurones by activation of P2X-receptors and distinct receptors for uracil nucleotides, respectively. The present study on cultured neurones of rat thoracolumbal paravertebral ganglia has analysed the involvement of action potentials and calcium influx in the nucleotide-induced transmitter release. ATP and UDP (100 mu M each) caused a marked release of previously incorporated [H-3]noradrenaline. The P2-receptor antagonists suramin (300 mu M) and cibacron blue 3GA (3 mu M) decreased the ATP-induced but not the UDP-induced release. The response to ATP was decreased by the sodium channel blocker tetrodotoxin (0.5 mu M; by 47%), by the N-type calcium channel blocker omega-conotoxin GVIA (100 nM; by 35%), and by the alpha(2)-adrenoceptor agonist UK-14,304 (1 mu M by 45%); it was not changed by the potassium channel blocker tetraethylammonium (10 mM). The response to UDP was abolished by tetrodotoxin, greatly decreased by omega-conotoxin (by 78%), also abolished by UK-14,304, and increased by tetraethylammonium (by 410%). ATP (100 mu M) caused a marked increase in intraaxonal free calcium as measured by fura-2 microfluorimetry. Withdrawal of extracellular calcium diminished the calcium response to ATP by 85%, and tetrodotoxin and omega-conotoxin diminished it by about 40%. As studied with the amphotericin B-perforated patch method, ATP (100 mu M) induced a large depolarisation and action potential firing. UDP (100 mu M) induced only a small depolarisation but it also elicited action potentials. UDP increased the excitability of the neurones. The results indicate that the ATP-induced release of noradrenaline depends on influx of calcium from the extracellular space. Calcium passes through two structures: volt age-gated channels and - probably - the P2X-receptor itself. Only that component of ATP-induced transmitter release which is triggered by opening of voltage-gated calcium channels is sensitive to modulation by alpha(2)-adrenoceptors. In contrast to ATP, the UDP-induced release of noradrenaline is entirely due to generation of action potentials followed by calcium influx through voltage-gated channels. All of the UDP-induced release is therefore sensitive to alpha(2)-adrenoceptor modulation.
引用
收藏
页码:360 / 369
页数:10
相关论文
共 54 条
[1]   PHARMACOLOGICAL INHIBITION OF THE M-CURRENT [J].
ADAMS, PR ;
BROWN, DA ;
CONSTANTI, A .
JOURNAL OF PHYSIOLOGY-LONDON, 1982, 332 (NOV) :223-262
[2]   MODULATORY ACTIONS OF ATP ON MEMBRANE-POTENTIALS OF BULLFROG SYMPATHETIC-GANGLION CELLS [J].
AKASU, T ;
HIRAI, K ;
KOKETSU, K .
BRAIN RESEARCH, 1983, 258 (02) :313-317
[3]   CULTURED CHICK SYMPATHETIC NEURONS - ATP-INDUCED NORADRENALINE RELEASE AND ITS BLOCKADE BY NICOTINIC RECEPTOR ANTAGONISTS [J].
ALLGAIER, C ;
WELLMANN, H ;
SCHOBERT, A ;
KURZ, G ;
VONKUGELGEN, I .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1995, 352 (01) :25-30
[5]  
BEAN BP, 1990, J NEUROSCI, V10, P11
[7]   UTP-TRIGGERED AND ATP-TRIGGERED TRANSMITTER RELEASE FROM RAT SYMPATHETIC NEURONS VIA SEPARATE RECEPTORS [J].
BOEHM, S ;
HUCK, S ;
ILLES, P .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 (05) :2341-2343
[8]   Inhibition of N-type calcium channels. The only mechanism by which presynaptic alpha(2)-autoreceptors control sympathetic transmitter release [J].
Boehm, S ;
Huck, S .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1996, 8 (09) :1924-1931
[9]  
BOEHM S, 1994, N-S ARCH PHARMACOL, V350, P454
[10]   Molecular cloning and characterization of rat P2Y4 nucleotide receptor [J].
Bogdanov, YD ;
Wildman, SS ;
Clements, MP ;
King, BF ;
Burnstock, G .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (03) :428-430